◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

HomeAll stocksA › AJ91

DocCheck AG (AJ91) Financial History

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Health Information Services · DATA UPDATED 2026-08-16

DocCheck AG (AJ91) operates in the Health Information Services industry and is headquartered in Cologne, Germany with about 414 employees. Its market capitalization is roughly €56 million. In the fiscal year ended 2025-12-31, AJ91 reported €55M in revenue and €5M in net income.

DocCheck AG provides community, agency, and e-commerce services for the healthcare sector in Europe. It focuses on agency, access, and retail businesses.

Interactive charts & full statements →

AJ91 Revenue & Earnings History — Annual Income Statement

Income statement2025-12-312024-12-312023-12-312022-12-312021-12-31
Total Revenue€55M€54M€53M€61M
Gross Profit€37M€36M€36M€38M
Operating Income (EBIT)€9M€6M€3M€9M
Net Income€5M€5M€2M€6M

EUR; €M / €B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

AJ91 Free Cash Flow History

Cash flow2025-12-312024-12-312023-12-312022-12-312021-12-31
Dividends Paid(€4M)(€2M)(€4M)(€5M)

EUR; €M / €B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

AJ91 Balance Sheet History

Balance sheet2025-12-312024-12-312023-12-312022-12-312021-12-31
Total Assets€56M€58M€56M€60M
Total Liabilities€14M€18M€18M€21M

EUR; €M / €B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive AJ91 viewer.

Other Companies in Health Information Services

← AIZAll “A” companiesAJAX →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.